INTRODUCTION Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are widely used in congestive heart failure and chronic kidney disease, but up to 40% of patients will experience aldosterone breakthrough, with aldosterone levels rising above pre-treatment levels after 6-12 months of renin-angiotensin-aldosterone system blockade. Aldosterone breakthrough has been associate...

experiments, for aqueous Cr(VI) solutions having low buffering capacities, over the Cr(VI) concentration range of 5 – 40 mg/L. The results showed that the initial Cr(VI) concentration significantly affects the reduction capacity of scrap iron. Maximum reduction capacity of scrap iron was observed at the beginning of the column experiments; the lower the Cr(VI) concentration, the greater the exp...